Journal of psychoactive drugs最新文献_第7页

Significant Psychedelic Experiences Evaluated for Mystical Characteristics Associated with Cannabis Use Reduction and Psychological Flexibility Improvement: A Naturalistic Cross-Sectional Retrospective Survey. 重要迷幻体验的神秘特征评估与减少使用大麻和提高心理灵活性有关：一项自然主义横断面回顾性调查。

IF 2.1 4区医学

Journal of psychoactive drugs Pub Date : 2024-07-03 DOI: 10.1080/02791072.2024.2375720

B Romeo, E Kervadec, B Fauvel, L Strika-Bruneau, A Amirouche, V Verroust, P Piolino, A Benyamina

{"title":"Significant Psychedelic Experiences Evaluated for Mystical Characteristics Associated with Cannabis Use Reduction and Psychological Flexibility Improvement: A Naturalistic Cross-Sectional Retrospective Survey.","authors":"B Romeo, E Kervadec, B Fauvel, L Strika-Bruneau, A Amirouche, V Verroust, P Piolino, A Benyamina","doi":"10.1080/02791072.2024.2375720","DOIUrl":"https://doi.org/10.1080/02791072.2024.2375720","url":null,"abstract":"Treating cannabis use disorder remains a significant challenge in the field of addiction medicine. Some recent studies point to psychedelic-assisted psychotherapy as a potential treatment option for substance use disorders. The objective of this study was therefore to explore the impact of naturalistic psychedelic experiences on cannabis use and psychological flexibility. An online retrospective survey was carried out on 152 cannabis users who also reported a significant experience induced by psychedelics in the past. Following a psychedelic experience, there was a significant and sustained reduction of average CUDIT score (p < .001), frequency of cannabis use (p < .001), and acute duration of daily intoxication (p < .001). Cannabis use reduction during the first month post-experience was significantly associated with the intensity of the mystical experience (p = .01). Participants reported a concomitant increased lasting improvement of psychological flexibility following the experience (p < .001), which was correlated to the intensity of the mystical experience during the first month post-experience (p = .04). This study demonstrates that naturalistic psychedelic experiences may be followed by a decrease in cannabis use. Positive health outcomes appear potentially connected to the intensity of the mystical experience, as well as an improvement in psychological flexibility.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"1-12"},"PeriodicalIF":2.1,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141498322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Sexualized drug use and chemsex: A bibliometric and content analysis of published literature. 性化药物使用和化学性行为：对已发表文献的文献计量和内容分析。

IF 2.1 4区医学

Journal of psychoactive drugs Pub Date : 2024-07-03 DOI: 10.1080/02791072.2024.2367614

Luke Muschialli, Justin C Yang, Teyl Engstrom, Cheneal Puljevic, Edoardo Beltazar, Emmanuel Beltazar, Owais Siddique, Jason Ferris, Dean J Connolly

{"title":"Sexualized drug use and chemsex: A bibliometric and content analysis of published literature.","authors":"Luke Muschialli, Justin C Yang, Teyl Engstrom, Cheneal Puljevic, Edoardo Beltazar, Emmanuel Beltazar, Owais Siddique, Jason Ferris, Dean J Connolly","doi":"10.1080/02791072.2024.2367614","DOIUrl":"10.1080/02791072.2024.2367614","url":null,"abstract":"Sexualized drug use (SDU) describes drug-facilitated sexual enhancement, and chemsex is an SDU subculture involving the use of specific drugs by men who have sex with men (MSM). This study aimed to identify research trends, foci, and themes within the SDU and chemsex-specific literature. The Web of Science Core Collection was searched with a list of SDU synonyms. All SDU-related articles were analyzed using the R package, bibliometrix. Full text review identified chemsex-specific records, and text was extracted verbatim for content analysis in Leximancer. The search returned 1,866 unique records. A total of 521 addressed SDU, and 301 papers specifically addressed chemsex. The small but growing SDU literature primarily addressed consensual encounters between MSM, and drug-facilitated assault experienced by women, in Western settings. Little attention was given to transgender communities or consensual SDU in cisgender heterosexual individuals. The literature primarily viewed SDU through a public health lens, specifically focusing on the risk conferred to sexual health.The SDU and chemsex-specific literature are potentially limited in scope and may inadequately capture the geographical, demographic, and cultural diversity of these phenomena. Future research should address the myriad social and health implications of SDU and chemsex participation across all relevant communities and settings.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"1-12"},"PeriodicalIF":2.1,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141498321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Psychedelic Experiences After Bereavement Improve Symptoms of Grief: The Influence of Emotional Breakthroughs and Challenging Experiences. 丧亲后的迷幻体验可改善悲伤症状：情感突破和挑战性体验的影响。

IF 2.1 4区医学

Journal of psychoactive drugs Pub Date : 2024-07-01 Epub Date: 2023-06-21 DOI: 10.1080/02791072.2023.2228303

Fiona Low, Mitch Earleywine

{"title":"Psychedelic Experiences After Bereavement Improve Symptoms of Grief: The Influence of Emotional Breakthroughs and Challenging Experiences.","authors":"Fiona Low, Mitch Earleywine","doi":"10.1080/02791072.2023.2228303","DOIUrl":"10.1080/02791072.2023.2228303","url":null,"abstract":"Grief, a common reaction to loss, can frequently become problematic or impairing. Available treatments for prolonged grief disorder are promising but leave room for considerable improvement. Qualitative accounts of psychedelic experiences after bereavement reveal themes that parallel core components of prolonged grief disorder therapy. However, few studies have investigated the therapeutic potential of psychedelics for symptoms of grief. The present study surveyed recreational psychedelic users (N = 363) who had suffered a bereavement event. They reported retrospective grief symptoms before and after the psychedelic experience as well as subjective reactions to the psychedelic, including emotional breakthroughs and challenging experiences. Results indicate improvements in grief symptoms after a psychedelic experience, with a large effect size (Cohen's d = 0.83). The occurrence of emotional breakthroughs was positively associated with improvements in symptoms of grief, while the converse relation was observed for challenging experiences. Findings provide preliminary evidence that support the development of a psychedelic-assisted therapy protocol to target symptoms of grief. Psychedelic-assisted therapy might offer an alternative to current grief treatment options.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"316-323"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9671388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Health Benefits and Positive Acute Effects of Psilocybin Consumption: A Quantitative Textual Analysis of User Self-Reported Data. 服用迷幻药对健康的益处和积极的急性效应：对使用者自述数据的定量文本分析。

IF 2.1 4区医学

Journal of psychoactive drugs Pub Date : 2024-07-01 Epub Date: 2023-06-22 DOI: 10.1080/02791072.2023.2226414

Bheatrix Bienemann, Amanda Rocha Barbosa, Lucas Villar Magalhães da Cruz, Marco Multedo, Daniel Mograbi

{"title":"Health Benefits and Positive Acute Effects of Psilocybin Consumption: A Quantitative Textual Analysis of User Self-Reported Data.","authors":"Bheatrix Bienemann, Amanda Rocha Barbosa, Lucas Villar Magalhães da Cruz, Marco Multedo, Daniel Mograbi","doi":"10.1080/02791072.2023.2226414","DOIUrl":"10.1080/02791072.2023.2226414","url":null,"abstract":"There has been growth in the use of psychedelics by the global population in recent years. In addition to recreational and ritualistic use, recent research into psychedelics has brought advances for treating mental disorders. Understanding the specific circumstances in which psilocybin leads to positive outcomes may have important implications for the future of its clinical use and for harm reduction initiatives. This study aimed to investigate the positive effects from the consumption of psilocybin through public online self-reports. We sought to investigate health benefits promoted by the consumption of the substance, positive acute effects, and contextual details of these experiences. We analyzed 846 reports with the assistance of the IRaMuTeQ textual analysis software, adopting the procedures of Descending Hierarchical Classification, Correspondence Factor Analysis, and Specificities Analysis. The texts were grouped in 5 clusters, describing the content of mental experiences, cognitive processes, somatic experiences, perceptual alterations, and context of administration. The findings of this study reinforce central axes of the psychedelic experience, such as the presence of somatic and visual alterations, connectedness and feeling one with the world and effects of setting, as well as the beneficial character of mystical experiences this substance promotes, and the importance of the ego-dissolution phenomenon.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"324-332"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9675987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Sex Moderates Associations Between Dimensions of Emotion Dysregulation and Problematic Cannabis Use. 性别可调节情绪失调维度与问题性吸食大麻之间的关系。

IF 2.1 4区医学

Journal of psychoactive drugs Pub Date : 2024-07-01 Epub Date: 2023-05-08 DOI: 10.1080/02791072.2023.2210552

Jessica M Cavalli, Anita Cservenka

{"title":"Sex Moderates Associations Between Dimensions of Emotion Dysregulation and Problematic Cannabis Use.","authors":"Jessica M Cavalli, Anita Cservenka","doi":"10.1080/02791072.2023.2210552","DOIUrl":"10.1080/02791072.2023.2210552","url":null,"abstract":"The current study examined whether sex moderates associations between emotion dysregulation (overall and six dimensions of emotion dysregulation) and problematic cannabis use. 741 adult past-month cannabis users (31.44% female) completed questionnaires on problematic cannabis use (Marijuana Problems Scale) and emotion dysregulation (Difficulties in Emotion Regulation Scale). Mann-Whitney U tests and hierarchical multiple linear regressions were performed. Male cannabis users reported greater difficulties with overall emotion dysregulation, nonacceptance, goals, impulse, strategies, and clarity. Overall emotion dysregulation, nonacceptance, goals, impulse, and strategies were associated with more severe problematic cannabis use, with relationships weaker in female cannabis users. Lack of emotional awareness was associated with less severe problematic cannabis use in male cannabis users only. Examining individual differences in emotion dysregulation as they relate to problematic cannabis use suggests that treatments may need to be tailored for male cannabis users with a focus on specific emotion dysregulation dimensions.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"342-352"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9487250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Pregabalin Qualitative Detection in Turkish Forensic Cases Between 2017 to 2018. 2017 年至 2018 年土耳其法医案例中的普瑞巴林定性检测。

IF 2.1 4区医学

Journal of psychoactive drugs Pub Date : 2024-07-01 Epub Date: 2023-06-21 DOI: 10.1080/02791072.2023.2226138

Ceyda Teker, Rukiye Aslan, Cahit İpekçi, Mehmet Tokdemir, Serap Annette Akgür

{"title":"Pregabalin Qualitative Detection in Turkish Forensic Cases Between 2017 to 2018.","authors":"Ceyda Teker, Rukiye Aslan, Cahit İpekçi, Mehmet Tokdemir, Serap Annette Akgür","doi":"10.1080/02791072.2023.2226138","DOIUrl":"10.1080/02791072.2023.2226138","url":null,"abstract":"Pregabalin (PGB) has been commonly subjected to diversion, from being a prescription drug to a recreational drug. In this study, pregabalin use (which is one of the substances subject to control in Turkey) and the concomitant use of other substances in cases admitted to the Izmir Forensic Medicine Institute was evaluated. Samples from 15,259 cases were screened, between June 2017 and December 2018, for the presence of PGB, and PGB positive cases were further analyzed. Of all cases screened, PGB was detected in 3.2% (n = 487). The mean age of PGB positive cases was 29.24 ± 10.34 years old (min: 14, max: 84), and 94% of them were male. Cannabis metabolite THC-COOH was the most common substance detected in the blood samples following PGB. Overall, 8 other substances were commonly used along with PGB. These substances were cannabis, morphine, hydromorphone, codeine, hydrocodone, heroin, paracetamol, and naproxen. Finally, we observed similar results in urine analysis. This research provides systematic data for PGB use in forensic cases in Turkey. The study findings indicate that PGB and multiple drug use increased over time, and providers should be particularly careful when prescribing PGB.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"380-386"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9769264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review. 迷幻药治疗抑郁症的潜在机制：系统回顾

IF 2.1 4区医学

Journal of psychoactive drugs Pub Date : 2024-07-01 Epub Date: 2023-06-29 DOI: 10.1080/02791072.2023.2223195

Harrison J Lee, Vivian Wl Tsang, Brandon S Chai, Michelle Cq Lin, Andrew Howard, Christopher Uy, Julius O Elefante

{"title":"Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review.","authors":"Harrison J Lee, Vivian Wl Tsang, Brandon S Chai, Michelle Cq Lin, Andrew Howard, Christopher Uy, Julius O Elefante","doi":"10.1080/02791072.2023.2223195","DOIUrl":"10.1080/02791072.2023.2223195","url":null,"abstract":"Evidence suggests that psilocybin has therapeutic benefit for treating depression. However, there is little consensus regarding the mechanism by which psilocybin elicits antidepressant effects. This systematic review summarizes existing evidence. Ovid MEDLINE, EMBASE, psychINFO, and Web of Science were searched, for both human and animal studies, using a combination of MeSH Terms and free-text keywords in September 2021. No other mood disorders or psychiatric diagnoses were included. Original papers in English were included. The PRISMA framework was followed for the screening of papers. Two researchers screened the retrieved articles from the literature search, and a third researcher resolved any conflicts. Of 2,193 papers identified, 49 were selected for full-text review. 14 articles were included in the qualitative synthesis. Six supported psilocybin's mechanism of antidepressant action via changes to serotonin or glutamate receptor activity and three papers found an increase in synaptogenesis. Thirteen papers investigated changes in non-receptor or pathway-specific brain activity. Five papers found changes in functional connectivity or neurotransmission, most commonly in the hippocampus or prefrontal cortex. Several neuroreceptors, neurotransmitters, and brain areas are thought to be involved in psilocybin's ability to mitigate depressive symptoms. Psilocybin appears to alter cerebral blood flow to the amygdala and prefrontal cortex, but the evidence on changes in functional connectivity and specific receptor activity remains sparse. The lack of consensus between studies suggests that psilocybin's mechanism of action may involve a variety of pathways, demonstrating the need for more studies on psilocybin's mechanism of action as an antidepressant.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"301-315"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9752192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Examining Symptoms of Stimulant Misuse and Community Support Among Members of a Recovery-Oriented Online Community. 研究以康复为导向的在线社区成员滥用兴奋剂的症状和社区支持。

IF 2.1 4区医学

Journal of psychoactive drugs Pub Date : 2024-07-01 Epub Date: 2023-06-29 DOI: 10.1080/02791072.2023.2228781

Erin Kasson, Lindsey M Filiatreau, Kevin Davet, Nina Kaiser, Georgi Sirko, Mehaly Bekele, Patricia Cavazos-Rehg

{"title":"Examining Symptoms of Stimulant Misuse and Community Support Among Members of a Recovery-Oriented Online Community.","authors":"Erin Kasson, Lindsey M Filiatreau, Kevin Davet, Nina Kaiser, Georgi Sirko, Mehaly Bekele, Patricia Cavazos-Rehg","doi":"10.1080/02791072.2023.2228781","DOIUrl":"10.1080/02791072.2023.2228781","url":null,"abstract":"Misuse of prescription and non-prescription stimulants and related overdose deaths represent a growing public health crisis that warrants immediate intervention. We examined 100 posts and their respective comments from a public, recovery-oriented Reddit community in January 2021 to explore content related to DSM-V stimulant use disorder symptoms, access and barriers to recovery, and peer support. Using inductive and deductive methods, a codebook was developed with the following primary themes: 1) DSM-V Symptoms and Risk Factors, 2) Stigma/Shame, 3) Seeking Advice or Information, 4) Supportive or Unsupportive Comments. In 37% of posts community members reported taking high doses and engaging in prolonged misuse of stimulants. Nearly half of posts in the sample (46%) were seeking advice for recovery, but 42% noted fear of withdrawal symptoms or a loss of productivity (18%) as barriers to abstinence or a reduction in use. Concerns related to stigma, shame, hiding use from others (30%), and comorbid mental health conditions (34%) were also noted. Social media content analysis allows for insight into information about lived experiences of individuals struggling with substance use disorders. Future online interventions should address recovery barriers related to stigma and shame as well as fears associated with the physical and psychological impact of quitting stimulant misuse.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"422-432"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10755072/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9782223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Caregivers' Attitudes Toward Treatment Length for Persons in Swedish Opioid Agonist Treatment. A Qualitative Interview Study. 护理人员对接受瑞典阿片类激动剂治疗者的治疗时间的态度。定性访谈研究。

IF 2.1 4区医学

Journal of psychoactive drugs Pub Date : 2024-07-01 Epub Date: 2023-06-23 DOI: 10.1080/02791072.2023.2228794

Christina Nehlin, Charlotte Wollert Brander, Caisa Öster

{"title":"Caregivers' Attitudes Toward Treatment Length for Persons in Swedish Opioid Agonist Treatment. A Qualitative Interview Study.","authors":"Christina Nehlin, Charlotte Wollert Brander, Caisa Öster","doi":"10.1080/02791072.2023.2228794","DOIUrl":"10.1080/02791072.2023.2228794","url":null,"abstract":"Although opioid agonist treatment (OAT) has several beneficial effects, the issue of optimal treatment length remains unresolved. It is plausible that caregivers' attitudes toward treatment length are of importance to whether, how and when tapering off will take place. In this study, we investigated caregivers' attitudes toward treatment length by interviewing 15 caregivers from a variety of professions working in seven OAT treatment programs in Sweden. Data were analyzed using applied thematic analysis. The participants were generally hesitant concerning the idea of tapering off. Few of them had experiences of patients tapering off successfully. Many of them never brought up the subject unless the patient did so her-/himself. Only younger, socially stable patients were perceived to be suitable for tapering off. Participants also expressed a need among staff for education and ethical discussions on treatment length. A person-centered focus may be promoted by recurrently discussing treatment goals and by co-operating with patients to map the recovery capital of those interested in tapering. To further support caregivers in developing person-centered care, more knowledge of opioid use disorder and professional and interprofessional discussions of caregivers' own attitudes and beliefs are paramount.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"373-379"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9670807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Associations Between Kratom-Related State Policy Environments and Kratom Use in a Nationally Representative Population in the United States. 美国具有全国代表性的人群中与 Kratom 相关的州政策环境与 Kratom 使用之间的关联。

IF 2.1 4区医学

Journal of psychoactive drugs Pub Date : 2024-07-01 Epub Date: 2023-06-12 DOI: 10.1080/02791072.2023.2223622

Matthew S Ellis, Mance E Buttram, Alyssa Forber, Joshua C Black

{"title":"Associations Between Kratom-Related State Policy Environments and Kratom Use in a Nationally Representative Population in the United States.","authors":"Matthew S Ellis, Mance E Buttram, Alyssa Forber, Joshua C Black","doi":"10.1080/02791072.2023.2223622","DOIUrl":"10.1080/02791072.2023.2223622","url":null,"abstract":"Limited research has resulted in conflicting views on the risks versus benefits associated with kratom use. Despite no federal policy in the United States, individual states have implemented diverging policies through kratom bans, and legalization and regulation through Kratom Consumer Protection Acts (KCPAs). The Survey of Non-Medical Use of Prescription Drugs (NMURx) Program employs nationally-representative, repeated cross-sectional surveys on drug use. In 2021, weighted prevalence of past-12 month kratom use was compared across three state legal frameworks: no overarching state policy, KCPAs, and state bans. There was lower estimated prevalence of kratom use in banned states (prevalence: 0.75% (0.44, 1.06) relative to states with a KCPA (1.20% (0.89, 1.51)), and relative to states with no policies (1.04% (0.94, 1.13), though odds of use were not significantly associated with policy type. Kratom use was significantly associated with medicated treatment for opioid use disorder. While there were observed differences in the prevalence of past-12 month kratom use by state policy type, low uptake mitigated meaningful distinctions by limiting statistical precision, and potentially confounding effects, such as accessibility online. Future kratom-related policy decisions should be informed through evidence-based research.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"333-341"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9615155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0